Unauthorised cancer drug in Zimbabwe raises patient safety concerns

The Lancet Oncology 2026

View at publisher

Authors: Paul Adepoju

DOI: 10.1016/s1470-2045(26)00057-4

Cited by: 0

Fields of Study & Subjects

Pharmaceutical Quality and Counterfeiting Pharmaceutical Economics and Policy Healthcare Regulation